Evidence map›Paper›PMID 30962580›Full record

ArticleLeukemia2019

The phosphatase UBASH3B/Sts-1 is a negative regulator of Bcr-Abl kinase activity and leukemogenesis.

Afsar A Mian, Ines Baumann, Marcus Liebermann, Florian Grebien, Giulio Superti-Furga, Martin Ruthardt, Oliver G Ottmann, Oliver Hantschel

Abstract readLetter
In one paragraph

Article in Leukemia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Afsar A MianDepartment of Haematology, Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.
Ines BaumannCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.
Marcus LiebermannDepartment of Hematology, Goethe University Frankfurt, Frankfurt/Main, Germany.
Florian GrebienCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID http://orcid.org/0000-0003-4289-2281
Giulio Superti-FurgaCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria.ORCID http://orcid.org/0000-0002-0570-1768
Martin RuthardtDepartment of Haematology, Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.
Oliver G OttmannDepartment of Haematology, Division of Cancer and Genetics, School of Medicine, Cardiff University, Cardiff, UK.
Oliver HantschelCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria. oliver.hantschel@epfl.ch.ORCID http://orcid.org/0000-0001-8569-8169

Funding

Cancer Research UK C7838/A15733
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsCarcinogenesisCell LineFusion Proteins, bcr-ablHEK293 CellsHumansImatinib MesylateMicePhosphoric Monoester HydrolasesPhosphorylationProtein Tyrosine PhosphatasesFusion Proteins, bcr-ablImatinib MesylatePhosphoric Monoester HydrolasesProtein Tyrosine PhosphatasesUBASH3B protein, human

Identifiers

PMID30962580
PMCPMC6756289

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.